MedTrace Logo

Cranberry Consumption Improves γδ T Cell Function

NCT01713829 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2014-01-14

No results posted yet for this study

Summary

The purpose of this study is to determine the extent to which consuming a cranberry beverage modifies immune function, specifically related to γδ T cells and other innate immune cells. It is hypothesized that cranberry components will interact with immune cells to activate signaling pathways that enhance cell function. Enhanced immune cell function should result in reduced number, duration, and severity of cold and flu symptoms.

Conditions

  • Healthy

Interventions

OTHER

Cranberry Beverage

8 oz cranberry beverage consumed daily for 12 weeks

OTHER

Placebo Beverage

8 oz placebo beverage consumed daily for 12 weeks

Sponsors & Collaborators

  • The Cranberry Institute

    collaborator OTHER

  • University of Florida

    lead OTHER

Principal Investigators

  • Susan S Percival, PhD · University of Florida

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-01-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01713829 on ClinicalTrials.gov